Novel Therapeutics
PHAR4813
This unit of study aims to expose students to emerging therapeutic and diagnostic biotechnologies. This unit expands on second and third year pharmaceutical science units of study by exploring novel and developing biotechnologies, such as gene therapy, vaccines, DNA arrays, cell therapies, novel diagnostic methods, new drug targets and drugs/therapies as well as clinical development processes. Sources of information for new biotechnology developments will be explored and practical exercises in interpreting and translating this information to patients and other health professionals will be provided. This unit of study will foster necessary skills to prepare pharmacists for their evolving roles associated with the choice, application and monitoring of new biotherapies. The exercises are designed to support the development of generic collaborative skills necessary for project work, such as planning and project management, conflict resolution and written and oral communication skills.
Unit of study details
Unit of study level: Honours
Credit points: 6
Commencing semesters: 1
Further unit of study information
Unit of study handbook: PHAR4813
Costs and scholarships information: Costs and Scholarships
Final dates to withdraw from units of study: Census Dates
Available for study abroad and exchange: Yes